Introduction
Organ transplantation is a lifesaving treatment for patients with organ failure. However, the shortage of donor organs limits the number of transplants that can be performed. In Spain, organ donation rates are high relative to other countries, but organ shortage remains a barrier to meeting demand. This paper analyzes the marketing mix and SWOT factors influencing organ donation and procurement in Spain to further propose strategies to increase donation and transplantation rates.
Spain is a leader in deceased organ donation, with a donation rate of 48 donors per million population (pmp) in 2021, compared to 36 donors on average across the European Union. However, family refusal rates for organ donation in Spain are around 20%, reducing potential donations. Significant significant waitlists for organ transplants also remain, indicating that supply still needs to meet demand. Increased organ donation and procurement require addressing barriers in the systems and processes for donation and transplantation, along with public perceptions and behaviours towards the donation.
This paper utilizes marketing mix concepts – analyzing the “4 P’s” of product, price, place and promotion – along with a SWOT analysis of strengths, weaknesses, opportunities and threats relevant to organ donation and procurement in Spain. This analysis proposes strategies and recommendations to increase deceased donation rates, improve procurement processes, reduce family refusals, address organ shortages, and enhance public support for donation. It is ultimately increasing the rate of lifesaving organ transplants across Spain.
Marketing Mix Analysis
Product
The “product” in organ donation and procurement encompasses the donated organs and the related processes and infrastructure to enable donation, retrieval, transport and transplantation. The key product features include organ quality and suitability, integrity of retrieval and transport conditions, and safety and effectiveness of procedures (Goldaracena et al., 2020). No financial cost or price is associated with donated organs for donors or recipients. For organ donors and their families, the decision to donate organs for transplantation represents an altruistic final act that creates meaning from the loss of life. Donation provides a sense of comfort that death can save other lives. For organ recipients, transplantation provides the priceless possibility of an extended lifespan and improved health and quality of life that would otherwise be unattainable (Tocher et al., 2019). For society, organ donation and transplantation benefit healthcare systems by reducing the costs of alternate treatments for end-stage organ disease. It also demonstrates social solidarity and community spirit by supporting vulnerable patients.
Risks exist in perceived failures in the integrity of the body after death for donors or in the quality and safety of procured organs. In some countries, negative media coverage of unethical organ trade also contributes to public mistrust. Cultural or religious beliefs may also view organ donation as taboo. Additionally, the complex logistics of time-sensitive donation processes involve the coordination of multiple stakeholders, with risks of breakdowns that can lead to the loss of potential donated organs.
Price
While the direct costs of donated organs are minimal for donors and absent for recipients, significant costs across the organ donation/transplantation system affect product pricing decisions and value propositions (Vargas et al., 2023). Procurement costs include surgical procedures, organ transport systems and hospital infrastructure. The Spanish National Transplant Organization (ONT) funds the national coordination of organ donation, while regional health authorities fund local transplant systems.
A key pricing challenge is the need to scale up infrastructure to meet the organ demand, which needs to catch up to the community’s willingness to donate. As an opt-out donation system, high public support for donation in Spain means that potential organ supply outpaces the health system’s capacity to retrieve and transplant organs. Strategic investment decisions are required to maximise lifesaving benefits from willing donors. Pricing decisions also influence organ quality, with health budgets affecting clinician training, operating facilities and technologies. Key considerations include streamlining costs through centralisation and specialisation, balanced against equitable access.
Place
The intricate logistics of organ retrieval, transport and transplant represent significant distribution challenges. The network includes over 150 hospitals authorized for retrieval and transplantation, managed by 17 regional coordinating offices overseen by the national ONT. Organisation at each level is critical for time-sensitive matching between donors and recipients. Spain’s opt-out consent model also increases reliance on seamless coordination. Legally, deceased individuals are presumed organ donors unless they have specifically opted out while alive, placing the onus on the health system to operationalize donation wishes (Viñuela-Prieto et al., 2021). Breakdowns anywhere in this complex chain – from identifying potential donors, obtaining family consent, and transporting surgical teams and organs to transplanting organs effectively can jeopardise the utilization of donated organs.
In Spain, complex algorithms are optimized for donor-recipient compatibility and transplant outcomes. Nevertheless, the unevenness persists. Different hospitals have variations in donation rates, which may indicate class differences in training, resources, or clinical leadership. The issue of uneven regional availability is another angle, as urban locations with an above-average percentage of blood donors’ willingness overwhelm local transplant opportunities. This means an increased organ supply rate bypassing local collections, thus negatively affecting donor lists of patients waiting for transplant procedures.
Promotion
Extensive national awareness campaigns promote organ donation in Spain as an altruistic community service that saves lives. These communicate positive social approval for donation decisions after death. Campaigns also aim to address knowledge gaps or objections inhibiting donation consent among families of potential donors. While less widely promoted, transplantation success stories highlight lifesaving impacts for recipients. Key national campaign messages emphasise the social benefits of increasing community organ supply to reduce preventable deaths for transplant candidates. This frames organ donation as a civic responsibility. Campaigns also reassure donors and families by emphasising professionalism in the maintenance of dead donors’ dignity during organ retrieval. Shared decision-making processes for families to consider donating are also promoted to ease consolation over losing loved ones.
Mass media channels, including television, radio, print, billboards and digital platforms, enable national coordination of public information campaigns by the ONT. Integrated campaign strategies facilitate consistent messages at regional/local levels, including through hospitals, churches and community networks (Vargas et al., 2023). While organ donation is widely accepted socially in Spain, perceptions vary across communities based on religion, culture, education, and values. Targeted regional or demographic messaging helps address context-specific barriers or information gaps. Spain’s promotional environment fosters positive social norms supporting organ donation and transplantation as a symbol of community solidarity. However, public perceptions, while positive, are somewhat passive rather than actively engaged. More impactful communications promoting specific donor registration could increase future procurement rates.
SWOT Analysis
Strengths
Spain has achieved record organ donation rates through an ‘opt-out’ consent model with national coordination via the ONT and clinical solid leadership in organ retrieval and transplantation. This regulatory approach reinforces donation and transplantation as a standard, supported practice. Additional systemic strengths include integrated IT systems and patient data protocols enabling efficient matching between donors and recipients. Public acceptance of organ donation is also a key strength, with high awareness and willingness to donate organs after death. Framing organ donation around social responsibility resonates positively in Spain across moral, ethical and religious dimensions, provides a supportive environment to nurture further growth in organ donation and addresses remaining community objections through targeted promotion campaigns (Tocher et al., 2019).
Weaknesses
While the Spanish model has brought donation rates to world-leading levels, at 48 donors, the rate needs to catch up to its true potential. Family objections prevent using 1 in 5 potential donations from eligible deceased donors. Current donation rates fail to meet transplantation demand, with 6,500 people on organ waiting lists in 2021. Variable performance across hospitals and regions also undermines efficiency. Additionally, specialists identify barriers in clinical quality, leadership and governance arrangements for organ donation processes. Inadequate reimbursements for organ procurement procedures strain resources (Goldaracena et al., 2020). Heavy workloads for transplantation coordinators also contribute to process breakdowns or data inconsistencies. Gaps and delays in reporting systems further hamper optimal organ allocation between regions.
Opportunities
Rising rates of ageing, chronic diseases and obesity in Spain will increase demand for organ transplants. There are also opportunities to learn lessons from regional programs performing strongly and to implement best practices across all health districts nationwide. Optimising donor detection processes and addressing family reluctance can achieve quick gains. Specialist donation nurses could support intensive care staff with delicate family discussions regarding donation. Further education for clinical staff on diagnosing brain death would help ensure that all potential organ donors are identified promptly. Policy and protocol refinements also offer potential gains. For example, faster patient data sharing between clinicians and transplant coordinators allows more timely matching with compatible recipients, reducing organ wastage (Tocher et al., 2019). Substantial opportunities remain to strengthen systems and community attitudes to realise more donations and transplants.
Threats
The COVID-19 pandemic severely disrupted non-urgent transplant procedures for over 12 months, causing lengthy delays that cost lives. Hospitals redeployed intensive care and anaesthesia teams to the pandemic response. Surgical resources were diverted to critical care, and donors/recipients faced increased health risks that temporarily contraindicated transplants. This crisis highlighted vulnerabilities in safeguarding existing donations and transplant capacity. Economic impacts also threaten the organ donation system. Budget cuts strain resources for organ procurement surgeries and specialist staff. Public mistrust of specific medical practices also poses risks (Vargas et al., 2023). For example, objections by some religious groups towards diagnosing neurological death using brain stem testing challenge clinical standards that define potential organ donors. Misinformation and ethical concerns also circulate regarding fairness in organ allocation processes. Additionally, burgeoning innovations in regenerative therapies, bioengineering, prosthetics, dialysis and mechanical organ support will increase future competition for organ transplantation. While these emerging technologies currently fall short of transplant outcomes, the long-term outlook may expand treatment alternatives that could displace donations.
Strategies and Recommendations
Strengthen clinical leadership and resources for organ donation. Appointing hospital and regional donation process leaders, alongside continuous training to embed best practices across procurement teams, will improve performance (Tocher et al., 2019). Expanding transplantation coordinator roles will also enhance family support and consent processes. Additional clinical specialists should be deployed to address regional disparities in organ donation rates. Increase community endorsement through targeted campaigns. Community-specific promotional campaigns, codesigned with cultural and faith-based leaders, can validate organ donation across diverse religious and moral perspectives. Testimonials from donor families and transplant recipients also make messages more relatable on an emotional level.
Promote donor pledges to increase consent. Prompting more citizens to register consent to donate organs after death formally will provide clarity to guide families in making decisions on their behalf and remove the burden for grieving relatives unsure if departing loved ones would approve of donating organs (Goldaracena et al., 2020). Automated donor registration checks during record updates for license/ID renewals or health visits can normalize consent. To address health system lags through coordinated planning, a national task force should undertake coordinated forecasting of organ donation and transplantation capacity requirements, would identify investment priorities to meet growth potential from increased donations. Central planning would also ensure balanced regional access. Expert analysis of transplantation success and organ wastage data can inform system efficiencies.
Conclusion
This paper has analyzed the marketing mix and SWOT factors influencing Spain’s organ donation and procurement environment. While Spain’s ‘opt-out’ consent model and the coordinated system have yielded, record donations, family refusals and health system capacity bottlenecks still limit transplant numbers. Substantial opportunities exist to build on the solid public acceptance of organ donation, increase clinical engagement in procurement, and implement efficiency reforms. Key recommendations center on fostering community motivation to donate through targeted campaigns while addressing logistical barriers in the complex retrieval, transport and transplantation processes. Promoting organ donor pledges and clinical leadership are also identified as priorities. With comprehensive strategies engaging all stakeholders, Spain can consolidate its position as a world leader in organ donation and transplantation to save more lives.
The analysis incorporated organ donation and procurement concepts across marketing mix factors – product, price, place and promotion – along with internal and external strengths, weaknesses, opportunities and threats. The recommendations and strategies aim to increase organ donation consent rates and improve technical capabilities for procurement and transplantation. Overall, the paper provides a framework to guide coordinated efforts by policymakers, clinicians and community advocates seeking to tackle the shortages in organ availability for lifesaving transplants.
References
Goldaracena, N., Cullen, J. M., Kim, D.-S., Ekser, B., & Halazun, K. J. (2020). Expanding the donor pool for liver transplantation with marginal donors. International Journal of Surgery, 82, 30–35. https://doi.org/10.1016/j.ijsu.2020.05.024
Tocher, J., Neades, B., Smith, G. D., & Kelly, D. (2019). The role of specialist nurses for organ donation: A solution for maximising organ donation rates? Journal of Clinical Nursing, 28(9-10), 2020–2027. https://doi.org/10.1111/jocn.14741
Vargas, P. A., Mohamad El Moheb, Henry, Z., Intagliata, N., Su, F., Sttots, M., Argo, C., Pelletier, S., Oberholzer, J., & Goldaracena, N. (2023). Survival outcomes in adult recipients using pediatric deceased donor liver grafts. A PSM analysis from the OPTN/UNOS liver transplant registry. Journal of Liver Transplantation, 9, 100135–100135. https://doi.org/10.1016/j.liver.2022.100135
Viñuela-Prieto, J. M., Escarpa Falcón, M. C., Candel, F. J., Mateos Rodríguez, A., Torres González, J. I., & Del Río Gallegos, F. (2021). Family Refusal to Consent Donation: Retrospective Quantitative Analysis of Its Increasing Tendency and the Associated Factors Over the Last Decade at a Spanish Hospital. Transplantation Proceedings, 53(7), 2112–2121. https://doi.org/10.1016/j.transproceed.2021.07.026
write